Vaccine vaccine associated with a lower risk of heart disease

People receiving a vaccine for shingles European Heart Journal Today (Tuesday).

The protective effect of the vaccine lasts up to eight years and is particularly intense for men, people under 60 years of age and those in unhealthy lifestyles, such as smoking, alcohol and being inactive.

The study was led by Professor Dong Keon Yon of the College of Medicine at Kyung Hee University, Seoul, South Korea.

The pebble causes a painful rash and can lead to serious complications, especially in older adults and people with weak immune system. Previous research shows that, without vaccination, about 30% of people can develop pebbles during their lifetime.

In addition to the rash, the pebbles have been linked to a higher risk of heart problems, so we wanted to know if the vaccination can reduce this risk. “

Professor Dong Keon Yon, College of Medicine at Kyung Hee University, Seoul, South Korea

The study included 1,271,922 people aged 50 and older living in South Korea. Researchers have gathered data, from 2012 on whether people have received pebble vaccine and combine it with data on cardiovascular health and their data to other factors that can affect health, such as age, gender, wealth and lifestyle.

The vaccine was a live zoster vaccine, which means that it contained a weakened form of Varicella Zoster virus that causes shingles. In many countries, this type of vaccine is now replaced by a non -living, recombinant vaccine, which means it contains a protein from the Zoster Varicella virus.

The study showed that among the people who received the vaccine, there was a total of 23% lower risk of cardiovascular events, with a 26% lower risk of significant cardiovascular events (stroke, heart attack or death from heart disease), 26% lower heart disease and 26% lower heart disease.

The protective effect was stronger in two to three years after a vaccine, the researchers found that the protection lasted for up to eight years.

Professor Yon said: “Our study suggests that the desert vaccine can help reduce the risk of heart disease, even in people without known risk factors.

“There are several reasons why the vaccine vaccine can help reduce heart disease.

“This is one of the largest and most comprehensive studies after a healthy general population for a period of up to 12 years. For the first time, this has allowed us to look at the association between vaccination vaccination and 18 different types of cardiovascular disease.

“However, as this study is based on an Asian group, the results may not apply to all populations, as the living zoster vaccine is not suitable for everyone, more research on recombinant vaccine must be examined.

Professor Yon and his colleagues are also planning to study the impact of the recombinant vaccine to determine if it has similar benefits to reduce heart disease.